Mostra i principali dati dell'item
Spread of Tst-positive Staphylococcus aureus strains belonging to ST30 clone among patients and healthcareworkers in two intensive care units
dc.creator | Papadimitriou-Olivgeris M., Drougka E., Fligou F., Dodou V., Kolonitsiou F., Filos K.S., Anastassiou E.D., Petinaki E., Marangos M., Spiliopoulou I. | en |
dc.date.accessioned | 2023-01-31T09:42:28Z | |
dc.date.available | 2023-01-31T09:42:28Z | |
dc.date.issued | 2017 | |
dc.identifier | 10.3390/toxins9090270 | |
dc.identifier.issn | 20726651 | |
dc.identifier.uri | http://hdl.handle.net/11615/77600 | |
dc.description.abstract | Staphylococcus aureus is a major cause of infections. Toxic shock syndrome toxin (TSST-1) and Panton-Valentine leukocidin (PVL) are associated with severe clinical syndromes. S. aureus colonizing isolates recovered from healthcare workers and patients in the intensive care unit (ICU) of a university hospital comprising Group A were compared with those from adult non-ICU carriers (Group B). mecA, lukS/lukF-PV (Panton-Valentine leukocidin, PVL), and tst (toxic shock syndrome toxin) gene carriage was detected by PCR. Clones were identified in all methicillin-resistant S. aureus (MRSA) and toxin-positive methicillin-susceptible strains (MSSA) by pulsed-field gel electrophoresis (PFGE), agr groups, and multi locus sequencing typing (MLST). Group A included 90 S. aureus isolates, whereas Group B 53. PVL was more frequently found among MRSA vs. MSSA (p < 0.001) and in strains of Group B as compared to Group A (p < 0.001), consistent with the spread of ST80-IV. Higher incidence of tst gene carriage was identified among MSSA vs. MRSA (P 0.005) belonging mainly to ST30, and Group A vs. Group B (P 0.002). The wide dissemination of ST80-IV mainly in the community is responsible for a high percentage of PVL-positive MRSA, while silent spread of tst-positive S. aureus clones among ICU patients and personnel poses a threat of hospital transmission and possible severe infections. © 2017 by the authors. | en |
dc.language.iso | en | en |
dc.source | Toxins | en |
dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029000829&doi=10.3390%2ftoxins9090270&partnerID=40&md5=8d1669417b55829ec39a632f815e625a | |
dc.subject | Panton Valentine leukocidin | en |
dc.subject | pseudomonic acid | en |
dc.subject | toxic shock syndrome toxin 1 | en |
dc.subject | antiinfective agent | en |
dc.subject | bacterial protein | en |
dc.subject | bacterial toxin | en |
dc.subject | enterotoxin | en |
dc.subject | enterotoxin F, Staphylococcal | en |
dc.subject | exotoxin | en |
dc.subject | leukocidin | en |
dc.subject | mecA protein, Staphylococcus aureus | en |
dc.subject | Panton-Valentine leukocidin | en |
dc.subject | penicillin binding protein | en |
dc.subject | superantigen | en |
dc.subject | adult | en |
dc.subject | antibiotic resistance | en |
dc.subject | antibiotic sensitivity | en |
dc.subject | Article | en |
dc.subject | bacterial clearance | en |
dc.subject | bacterial colonization | en |
dc.subject | bacterium carrier | en |
dc.subject | bacterium isolation | en |
dc.subject | controlled study | en |
dc.subject | disease transmission | en |
dc.subject | disk diffusion | en |
dc.subject | gene frequency | en |
dc.subject | gene sequence | en |
dc.subject | health care personnel | en |
dc.subject | hospital infection | en |
dc.subject | human | en |
dc.subject | infection control | en |
dc.subject | intensive care unit | en |
dc.subject | major clinical study | en |
dc.subject | methicillin resistant Staphylococcus aureus infection | en |
dc.subject | minimum inhibitory concentration | en |
dc.subject | molecular cloning | en |
dc.subject | nonhuman | en |
dc.subject | polymerase chain reaction | en |
dc.subject | Staphylococcus aureus | en |
dc.subject | cross infection | en |
dc.subject | drug effect | en |
dc.subject | genetics | en |
dc.subject | Greece | en |
dc.subject | health care personnel | en |
dc.subject | intensive care unit | en |
dc.subject | isolation and purification | en |
dc.subject | methicillin resistance | en |
dc.subject | microbial sensitivity test | en |
dc.subject | microbiology | en |
dc.subject | multilocus sequence typing | en |
dc.subject | pulsed field gel electrophoresis | en |
dc.subject | Staphylococcus aureus | en |
dc.subject | Staphylococcus infection | en |
dc.subject | university hospital | en |
dc.subject | Anti-Bacterial Agents | en |
dc.subject | Bacterial Proteins | en |
dc.subject | Bacterial Toxins | en |
dc.subject | Cross Infection | en |
dc.subject | Electrophoresis, Gel, Pulsed-Field | en |
dc.subject | Enterotoxins | en |
dc.subject | Exotoxins | en |
dc.subject | Greece | en |
dc.subject | Health Personnel | en |
dc.subject | Hospitals, University | en |
dc.subject | Humans | en |
dc.subject | Intensive Care Units | en |
dc.subject | Leukocidins | en |
dc.subject | Methicillin Resistance | en |
dc.subject | Microbial Sensitivity Tests | en |
dc.subject | Multilocus Sequence Typing | en |
dc.subject | Penicillin-Binding Proteins | en |
dc.subject | Staphylococcal Infections | en |
dc.subject | Staphylococcus aureus | en |
dc.subject | Superantigens | en |
dc.subject | MDPI AG | en |
dc.title | Spread of Tst-positive Staphylococcus aureus strains belonging to ST30 clone among patients and healthcareworkers in two intensive care units | en |
dc.type | journalArticle | en |
Files in questo item
Files | Dimensione | Formato | Mostra |
---|---|---|---|
Nessun files in questo item. |